213-501-6

Applied Filters:

Keyword:'213-501-6'

Showing 1-1 of 1 result for "213-501-6" within Papers

Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.

Fiona Bath-Hextall et al.

The Lancet. Oncology, 15(1), 96-105 (2013-12-18)

Basal-cell carcinoma is the most common form of skin cancer and its incidence is increasing worldwide. We aimed to assess the effectiveness of imiquimod cream versus surgical excision in patients with low-risk basal-cell carcinoma. We did a multicentre, parallel-group, pragmatic

Page 1 of 1